fenoldopam has been researched along with staurosporine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aperia, A; Eklöf, AC; Greengard, P; Ibarra, F; Svensson, LB | 1 |
Arnaldo, FB; Concepcion, GP; Felder, RA; Han, W; Jose, PA; Li, H; Quinn, MT; Villar, VA; Yu, P | 1 |
2 other study(ies) available for fenoldopam and staurosporine
Article | Year |
---|---|
Bidirectional regulation of Na+,K(+)-ATPase activity by dopamine and an alpha-adrenergic agonist.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Alkaloids; Animals; Calcimycin; Denervation; Dopamine; Dopamine Agents; Ethers, Cyclic; Fenoldopam; In Vitro Techniques; Kidney; Kidney Tubules; Kinetics; Male; Okadaic Acid; Oxymetazoline; Protein Kinase C; Rats; Rats, Sprague-Dawley; Sodium; Sodium-Potassium-Exchanging ATPase; Staurosporine; Tacrolimus | 1993 |
Dopamine D1 receptor-mediated inhibition of NADPH oxidase activity in human kidney cells occurs via protein kinase A-protein kinase C cross talk.
Topics: Cell Line, Transformed; Cyclic AMP-Dependent Protein Kinases; Dopamine; Enzyme Activation; Fenoldopam; Gene Expression; Humans; Kidney; NADPH Oxidases; Phosphorylation; Protein Isoforms; Protein Kinase C; Protein Kinase Inhibitors; Receptors, Dopamine D1; RNA, Small Interfering; Signal Transduction; Staurosporine; Tetradecanoylphorbol Acetate | 2011 |